Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Global White Matter Changes and Associations with Cognition in Pediatric Sickle Cell Disease

Aliyah Allick, Emily Rao, James F. Casella, Keith Slifer, Alicia Cannon, Hangyi Jiang, Eric Chin, Eboni Lance

Blood (2023) 142 (Supplement 1): 1146.

https://doi.org/10.1182/blood-2023-181143

Published: 2023

Journal Articles

Neurodevelopmental Screening in Young Children with Sickle Cell Disease

Chi Aguwa, Alicia D. Cannon, James F. Casella, Bruce K. Shapiro, Eboni I. Lance

Blood (2021) 138 (Supplement 1): 2050.

https://doi.org/10.1182/blood-2021-152015

Published: 2021

Journal Articles

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Eboni I. Lance, MD, Alicia D. Cannon, PhD, Bruce K. Shapiro, MD, Michael V. Johnston, MD, James F. Casella, MD

Blood (2019) 134 (Supplement_1): 1016.

https://doi.org/10.1182/blood-2019-121968

Published: 2019

Journal Articles

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Eboni I. Lance, MD, Lisa Faulcon, MD, Zongming Fu, PhD, Jun Yang, PhD, Donna Whyte, MD, John J. Strouse, MD, PhD, Emily Barron-Casella, PhD, Kimberly Jones, Jennifer Van Eck, PhD, James F. Casella, MD, Allen Everett, MD

Blood (2019) 134 (Supplement_1): 2296.

https://doi.org/10.1182/blood-2019-122015

Published: 2019

Journal Articles

Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease

Christy Sadreameli, MD, M.H.S., Benjamin Kopp, MD, M.P.H., Susan E Creary, MD, Emily Jacobs, B.S., John J Strouse, MD PhD, Sharon A. McGrath-Morrow, MD, James F. Casella, MD, Elizabeth C. Matsui

Blood (2018) 132 (Supplement 1): 3676.

https://doi.org/10.1182/blood-2018-99-119743

Published: 2018

Journal Articles

Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History

Wenbo Li, PhD, Xiang Xu, PhD, Peiying Liu, PhD, Emily Jacobs, B.S., John J. Strouse, MD PhD, James F. Casella, MD, Hanzhang Lu, PhD, Peter van Zijl, PhD, Qin Qin, PhD

Blood (2017) 130 (Supplement 1): 3524.

https://doi.org/10.1182/blood.V130.Suppl_1.3524.3524

Published: 2017

Journal Articles

Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia

Shruti Chaturvedi, Pallav Bhatnagar, Christopher J. Bean, Martin H. Steinberg, Jaqueline N. Milton, James F. Casella, Emily Barron-Casella, Dan E. Arking, Michael R. DeBaun

Blood (2017) 130 (5): 686–688.

https://doi.org/10.1182/blood-2017-02-769661

Published: 2017

Includes: Supplemental data

Journal Articles

Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial

James C. Gay, MD MMHC, Timothy McCavit, MD, David Bundy, MD MPH, Allison King, MD MPH, PhD, Harold P. Lehman, MD, John J. Strouse, MD PhD, James F. Casella, MD, Mark J. Rodeghier, PhD, Michael DeBaun, MD

Blood (2016) 128 (22): 3655.

https://doi.org/10.1182/blood.V128.22.3655.3655

Published: 2016

Journal Articles

Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospital Discharge and Re-Admission

Mehdi Nouraie, MD PhD, Debra L Weiner, MD, Mariana Hildesheim, MS, Ward Hagar, MD, Oswaldo L Castro, MD, Sophie Lanzkron, MD MHS, Victor R. Gordeuk, MD, James F. Casella, MD, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2016) 128 (22): 3662.

https://doi.org/10.1182/blood.V128.22.3662.3662

Published: 2016

Journal Articles

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Odianosen Eigbire-Molen, Deepika S. Darbari, MD, Maria R. Ponisio, MD, Mikhail V. Milchenko, PhD, Mark J. Rodeghier, PhD, James F. Casella, MD, Robert McKinstry, MD PhD, Michael R. DeBaun, MD MPH

Blood (2015) 126 (23): 546.

https://doi.org/10.1182/blood.V126.23.546.546

Published: 2015

Journal Articles

Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy

Lauren M Beverung, MS, PhD, John J. Strouse, MD PhD, Monica L. Hulbert, MD, Kathleen A Neville, MD MS, Robert I. Liem, MD, Baba PD Inusa, MD FRCPCH, DCP, Beng Fuh, MD, Allison King, MD MPH, Emily R. Meier, MD, James F. Casella, MD, Michael R. DeBaun, MD MPH, Julie A. Panepinto, MD MSPH

Blood (2014) 124 (21): 2167.

https://doi.org/10.1182/blood.V124.21.2167.2167

Published: 2014

Journal Articles

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Howard M. Lederman, MD, PhD, Margaret A. Connolly, PhD, Ram Kalpatthi, MD, Russell E. Ware, MD, PhD, Winfred C. Wang, MD, Lori Luchtman-Jones, MD, Myron Waclawiw, PhD, Jonathan C. Goldsmith, MD, James F. Casella, MD

Blood (2012) 120 (21): 243.

https://doi.org/10.1182/blood.V120.21.243.243

Published: 2012

Journal Articles

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease

Christopher J. Bean, Sheree L. Boulet, Dorothy Ellingsen, Meredith E. Pyle, Emily A. Barron-Casella, James F. Casella, Amanda B. Payne, Jennifer Driggers, Heidi A. Trau, Genyan Yang, Kimberly Jones, Solomon F. Ofori-Acquah, W. Craig Hooper, Michael R. DeBaun

Blood (2012) 120 (18): 3822–3828.

https://doi.org/10.1182/blood-2011-06-361642

Published: 2012

Includes: Supplemental data

Journal Articles

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans

Blood (2012) 120 (9): 1961–1962.

https://doi.org/10.1182/blood-2012-06-432849

Published: 2012

Journal Articles

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure

Blood (2012) 119 (16): 3684–3690.

https://doi.org/10.1182/blood-2011-05-349621

Published: 2012

Journal Articles

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Bruce W Thompson, PhD, Winfred C Wang, MD, Scott T. Miller, MD, Zora R. Rogers, MD, Russell E. Ware, MD, PhD, Courtney D. Thornburg, MD, MS, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Rathi V. Iyer, MD, James F. Casella, MD

Blood (2011) 118 (21): 2134.

https://doi.org/10.1182/blood.V118.21.2134.2134

Published: 2011

Journal Articles

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Zora R. Rogers, MD, Billie Fish, CCRP, Zhaoyu Luo, PhD, Rathi V. Iyer, MD, Courtney D. Thornburg, MD, MS, Sharada A. Sarnaik, MD, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Sherron M. Jackson, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ofelia A. Alvarez, MD, Jonathan C. Goldsmith, MD, Scott T. Miller, MD, Winfred C. Wang, MD

Blood (2011) 118 (21): 7.

https://doi.org/10.1182/blood.V118.21.7.7

Published: 2011

Journal Articles

ACUTE CHEST SYNDROME with RESPIRATORY Syncytial VIRUS and SEASONAL INFLUENZA In CHILDREN with SICKLE CELL DISEASE

John J. Strouse, MD, Sara C Sadreameli, MD, James F. Casella, MD

Blood (2011) 118 (21): 4845.

https://doi.org/10.1182/blood.V118.21.4845.4845

Published: 2011

Journal Articles

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

Monica L. Hulbert, Robert C. McKinstry, JoAnne L. Lacey, Christopher J. Moran, Julie A. Panepinto, Alexis A. Thompson, Sharada A. Sarnaik, Gerald M. Woods, James F. Casella, Baba Inusa, Jo Howard, Fenella J. Kirkham, Kofi A. Anie, Jonathan E. Mullin, Rebecca Ichord, Michael Noetzel, Yan Yan, Mark Rodeghier, Michael R. DeBaun

Blood (2011) 117 (3): 772–779.

https://doi.org/10.1182/blood-2010-01-261123

Published: 2011

Journal Articles

Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

Jeffrey D. Lebensburger, DO, Scott T Miller, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ming Lu, MS, Rathi V. Iyer, MD, Zora R. Rogers, MD, Winfred C. Wang, MD

Blood (2010) 116 (21): 1631.

https://doi.org/10.1182/blood.V116.21.1631.1631

Published: 2010

NARROW

Global White Matter Changes and Associations with Cognition in Pediatric Sickle Cell Disease

Neurodevelopmental Screening in Young Children with Sickle Cell Disease

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease

Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History

Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia

Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial

Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospital Discharge and Re-Admission

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

ACUTE CHEST SYNDROME with RESPIRATORY Syncytial VIRUS and SEASONAL INFLUENZA In CHILDREN with SICKLE CELL DISEASE

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only